Literature DB >> 15675962

Distinction of desmoplastic melanoma from non-desmoplastic melanoma by gene expression profiling.

Klaus J Busam1, Hui Zhao, Daniel G Coit, Derya Kucukgol, Achim A Jungbluth, Jennifer Nobrega, Agnes Viale.   

Abstract

Desmoplastic melanoma (DM) is a variant of melanoma characterized by the presence of amelanotic fusiform melanocytes dispersed in a prominent collagenous stroma. DM behaves differently from conventional non-desmoplastic melanoma (NDM). It has a higher tendency for local recurrence and is less likely to metastasize to regional lymph nodes. In this study, we explored the possibility of distinguishing DM from NDM by gene expression profiling. RNA samples from ten primary cutaneous melanomas of similar depth of invasion were analyzed using the Affymetrix U133A oligonucleotide platform. Four tumors were DM, five were ND, and one tumor showed combined features of desmoplastic and conventional. Hierarchical cluster analysis clearly separated DM from NDM. The expression of a number of melanocyte differentiation genes was decreased in DM compared with NDM, which corresponded to immunohistochemical results. Various genes were upregulated in DM, including neurotrophic factors and genes involved in extracellular matrix production. A novel finding was the high expression of clusterin in DM, which was confirmed by immunohistochemical studies. Our results from gene expression profiling validate the distinction of DM from NDM. They also provide the opportunity to learn more about the biology of DM which had previously not yet been associated with this variant of melanoma.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15675962     DOI: 10.1111/j.0022-202X.2004.23600.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  13 in total

1.  Neurotropic melanoma: an analysis of the clinicopathological features, management strategies and survival outcomes for 671 patients treated at a tertiary referral center.

Authors:  Alexander H R Varey; Chris Goumas; Angela M Hong; Graham J Mann; Gerald B Fogarty; Jonathan R Stretch; Robyn P M Saw; Andrew J Spillane; Kerwin F Shannon; Kenneth J Lee; Michael J Quinn; John F Thompson; Richard A Scolyer
Journal:  Mod Pathol       Date:  2017-07-21       Impact factor: 7.842

Review 2.  [Histological spectrum of malignant melanoma].

Authors:  T Brenn
Journal:  Pathologe       Date:  2015-02       Impact factor: 1.011

3.  GENE PROFILING: IMPLICATIONS IN DERMATOLOGY.

Authors:  Miroslav Blumenberg; Marjana Tomic-Canic
Journal:  Expert Rev Dermatol       Date:  2007

Review 4.  Clinical utilities and biological characteristics of melanoma sentinel lymph nodes.

Authors:  Dale Han; Daniel C Thomas; Jonathan S Zager; Barbara Pockaj; Richard L White; Stanley Pl Leong
Journal:  World J Clin Oncol       Date:  2016-04-10

5.  Protein Expression Analysis of Melanocyte Differentiation Antigen TRP-2.

Authors:  Francesca Avogadri; Sacha Gnjatic; Jodie Tassello; Denise Frosina; Nicole Hanson; Megan Laudenbach; Erika Ritter; Taha Merghoub; Klaus J Busam; Achim A Jungbluth
Journal:  Am J Dermatopathol       Date:  2016-03       Impact factor: 1.533

6.  Functional RET G691S polymorphism in cutaneous malignant melanoma.

Authors:  N Narita; A Tanemura; R Murali; R A Scolyer; S Huang; T Arigami; S Yanagita; K K Chong; J F Thompson; D L Morton; D S Hoon
Journal:  Oncogene       Date:  2009-06-29       Impact factor: 9.867

Review 7.  Desmoplastic melanoma: a review.

Authors:  Lucy L Chen; Natalia Jaimes; Christopher A Barker; Klaus J Busam; Ashfaq A Marghoob
Journal:  J Am Acad Dermatol       Date:  2012-12-23       Impact factor: 11.527

Review 8.  Biomarkers in melanoma.

Authors:  H Gogas; A M M Eggermont; A Hauschild; P Hersey; P Mohr; D Schadendorf; A Spatz; R Dummer
Journal:  Ann Oncol       Date:  2009-08       Impact factor: 32.976

9.  SKINOMICS: Transcriptional Profiling in Dermatology and Skin Biology.

Authors:  Miroslav Blumenberg
Journal:  Curr Genomics       Date:  2012-08       Impact factor: 2.236

10.  Profiling of serum and tissue high abundance acute-phase proteins of patients with epithelial and germ line ovarian carcinoma.

Authors:  Yeng Chen; Boon-Kiong Lim; Suat-Cheng Peh; Puteri Shafinaz Abdul-Rahman; Onn Haji Hashim
Journal:  Proteome Sci       Date:  2008-07-18       Impact factor: 2.480

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.